Lifecare Q3 2023: Injection of growth capital sets the stage for an eventful year - Redeye

Redeye expects an eventful 2024 for Lifecare following the Q3 report, which sported slightly higher revenues and lower costs than anticipated. We largely maintain our estimates and slightly increase our base case.

Länk till analysen i sin helhet: https://www.redeye.se/research/959556/lifecare-q2-2023-injection-of-growth-capital-sets-the-stage-for-an-eventful-year?utm_source=finwire&utm_medium=RSS